Literature DB >> 24860190

Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis.

Colin I Carlock1, Jean Wu1, Cindy Zhou1, Kiana Tatum1, Henry P Adams2, Filemon Tan3, Yahuan Lou4.   

Abstract

Ovaries are among the most active organs. Frequently occurring events such as ovulation and ovarian atresia are accompanied with tissue destruction and repairing. Critical roles of immune cells or molecules in those events have been well recognized. IL-33 is a new member of the IL-1 cytokine gene family. Recent studies suggest its roles beyond immune responses. We systemically examined its expression in ovaries for its potential roles in ovarian functions. During ovulation, a high level of IL-33 was transiently expressed, making it the most significantly upregulated immune gene. During estrous cycle, IL-33 expression levels fluctuated along with numbers of ovarian macrophages and atresia wave. Cells with nuclear form of IL-33 (nIL-33(+) cells) were mostly endothelial cells of veins, either in the inner layer of theca of ovulating follicles during ovulation, or surrounding follicles during estrous cycle. Changes in number of nIL-33(+) cells showed a tendency similar to that in IL-33 mRNA level during estrous cycle. However, the cell number sharply declined before a rapid increase of macrophages and a surge of atresia. The decline in nIL-33(+) cell number was coincident with detection of higher level of the cytokine form of IL-33 by Western blot, suggesting a release of cytokine form of IL-33 before the surge of macrophage migration and atresia. However, IL-33 Ab, either by passive transfer or immunization, showed a limited effect on ovulation or atresia. It raises a possibility of IL-33's role in tissue homeostasis after ovarian events, instead of a direct involvement in ovarian functions.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24860190      PMCID: PMC4084839          DOI: 10.4049/jimmunol.1400381

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  Ovarian expression of chemokines and their receptors.

Authors:  Cindy Zhou; Jason Borillo; Jean Wu; Lisa Torres; Ya-Huan Lou
Journal:  J Reprod Immunol       Date:  2004-08       Impact factor: 4.054

Review 3.  Macrophage contributions to ovarian function.

Authors:  Ruijin Wu; Kylie H Van der Hoek; Natalie K Ryan; Robert J Norman; Rebecca L Robker
Journal:  Hum Reprod Update       Date:  2004 Mar-Apr       Impact factor: 15.610

4.  Ovarian phagocyte subsets and their distinct tissue distribution patterns.

Authors:  Colin Carlock; Jean Wu; Cindy Zhou; April Ross; Henry Adams; Yahuan Lou
Journal:  Reproduction       Date:  2013-10-01       Impact factor: 3.906

5.  The alarmin IL-33 is a notch target in quiescent endothelial cells.

Authors:  Eirik Sundlisaeter; Reidunn J Edelmann; Johanna Hol; Jon Sponheim; Axel M Küchler; Miriam Weiss; Irina A Udalova; Kim S Midwood; Monika Kasprzycka; Guttorm Haraldsen
Journal:  Am J Pathol       Date:  2012-07-16       Impact factor: 4.307

Review 6.  Ovulation: new dimensions and new regulators of the inflammatory-like response.

Authors:  JoAnne S Richards; Darryl L Russell; Scott Ochsner; Lawrence L Espey
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

7.  Expression, hormonal regulation, and cyclic variation of chemokines in the rat ovary: key determinants of the intraovarian residence of representatives of the white blood cell series.

Authors:  Kenneth H H Wong; Hiroaki Negishi; Eli Y Adashi
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

8.  Macrophages regulate corpus luteum development during embryo implantation in mice.

Authors:  Alison S Care; Kerrilyn R Diener; Melinda J Jasper; Hannah M Brown; Wendy V Ingman; Sarah A Robertson
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

9.  Systemic inflammation is associated with ovarian follicular dynamics during the human menstrual cycle.

Authors:  Kathryn B H Clancy; Angela R Baerwald; Roger A Pierson
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.

Authors:  Svitlana Demyanets; Christoph Kaun; Richard Pentz; Konstantin A Krychtiuk; Sabine Rauscher; Stefan Pfaffenberger; Andreas Zuckermann; Arezu Aliabadi; Marion Gröger; Gerald Maurer; Kurt Huber; Johann Wojta
Journal:  J Mol Cell Cardiol       Date:  2013-04-06       Impact factor: 5.000

View more
  15 in total

Review 1.  Role of the IL-33/ST2 receptor axis in ovarian cancer progression.

Authors:  Ning Liu; Jintong Chen; Yinghua Zhao; Mingyue Zhang; Li Piao; Siqing Wang; Ying Yue
Journal:  Oncol Lett       Date:  2021-04-29       Impact factor: 2.967

2.  A network map of IL-33 signaling pathway.

Authors:  Sneha M Pinto; Yashwanth Subbannayya; D A B Rex; Rajesh Raju; Oishi Chatterjee; Jayshree Advani; Aneesha Radhakrishnan; T S Keshava Prasad; Mohan R Wani; Akhilesh Pandey
Journal:  J Cell Commun Signal       Date:  2018-04-28       Impact factor: 5.782

3.  IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus.

Authors:  Kathleen Bartemes; Chien-Chang Chen; Koji Iijima; Li Drake; Hirohito Kita
Journal:  J Immunol       Date:  2017-11-13       Impact factor: 5.422

4.  Dynamic Expression of Interleukin-33 and ST2 in the Mouse Reproductive Tract Is Influenced by Superovulation.

Authors:  Salma Begum; Barry E Perlman; Nuriban Valero-Pacheco; Valerie O'Besso; Tracy Wu; Sara S Morelli; Aimee M Beaulieu; Nataki C Douglas
Journal:  J Histochem Cytochem       Date:  2020-02-28       Impact factor: 2.479

Review 5.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

6.  IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development.

Authors:  Matthew T Stier; Ramkrishna Mitra; Lindsay E Nyhoff; Kasia Goleniewska; Jian Zhang; Matthew V Puccetti; Holly C Casanova; Adam C Seegmiller; Dawn C Newcomb; Peggy L Kendall; Christine M Eischen; R Stokes Peebles
Journal:  J Immunol       Date:  2019-08-07       Impact factor: 5.422

7.  IL-33 is required for disposal of unnecessary cells during ovarian atresia through regulation of autophagy and macrophage migration.

Authors:  Jean Wu; Colin Carlock; Cindy Zhou; Susumu Nakae; John Hicks; Henry P Adams; Yahuan Lou
Journal:  J Immunol       Date:  2015-01-23       Impact factor: 5.422

Review 8.  Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis.

Authors:  Ajithkumar Vasanthakumar; Axel Kallies
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

Review 9.  Macrophages: an indispensable piece of ovarian health.

Authors:  Zijing Zhang; Lu Huang; Lynae Brayboy
Journal:  Biol Reprod       Date:  2021-03-11       Impact factor: 4.285

Review 10.  Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.

Authors:  Ari B Molofsky; Adam K Savage; Richard M Locksley
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.